Active Ingredient: TASIMELTEON
Proprietary Name: TASIMELTEON
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211654
Product Number: 001
Approval Date: Jan 12, 2023
Applicant Holder Full Name: MSN LABORATORIES PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information